Patents by Inventor Raymond Youssefyeh

Raymond Youssefyeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzoxepins as intermediates to 5HT.sub.3 antagonists
    Patent number: 4924010
    Abstract: Certain specific substituted 9-N-(1-azabicycolo-[2.2.2.]octan-3-yl)carboxamido-2,3,4,5-tetrahydro-1-ben zoxepins and their valuable use as 5-HT.sub.3 antagonists having CNS and gastric prokinetic activity and void of any significant D.sub.2 receptor binding properties are disclosed. Methods for their preparation also are described.
    Type: Grant
    Filed: July 31, 1989
    Date of Patent: May 8, 1990
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: Raymond Youssefyeh, Scott I. Klein, Henry F. Campbell, Donald E. Kuhla
  • Quinolinyl ether or thioether tetrazoles as agents for the treatment of hypersensitive ailments
    Patent number: 4874769
    Abstract: This invention relates to certain quinolyl ether and thioether tetrazoles and their use as valuable pharmaceutical agents for the treatment of hypersensitive ailments, particularly as lipoxygenase inhibitors and/or leukotriene antagonists possessing anti-inflammatory and antiallergic properties.
    Type: Grant
    Filed: January 5, 1988
    Date of Patent: October 17, 1989
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: Raymond Youssefyeh, Utpal Chakraborty, Ernest Magnien, Rohit Desai, Thomas D-Y Lee
  • Certain benzoxepins and their pharmaceutical compositions and methods
    Patent number: 4859683
    Abstract: Certain specific substituted 9-N-(1-azabicyclo[3.3.1.]nonan-4-yl)carboxamido-2,3,4,5-tetrahydro-1-benzo xepins and their valuable use as 5-HT.sub.3 antagonists having CNS and gastric prokinetic activity and void of any significant D.sub.2 receptor binding properties are disclosed. Methods for their preparation also are described.
    Type: Grant
    Filed: February 4, 1988
    Date of Patent: August 22, 1989
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: Raymond Youssefyeh, Scott I. Klein, Henry F. Campbell, Donald E. Kuhla
  • Quinuclidyl benzoxepins as 5-HT.sub.3 antagonists
    Patent number: 4857517
    Abstract: Certain specific substituted 9-N-(1-azabicyclo-[2.2.2.]octan-3-yl)carboxamido-2,3,4,5-tetrahydro-1-benz oxepins and their valuable use as 5-HT.sub.3 antagonists having CNS and gastric prokinetic acticity and void of any significant D.sub.2 receptor binding properties are disclosed. Methods for their preparation also are described.
    Type: Grant
    Filed: February 4, 1988
    Date of Patent: August 15, 1989
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: Raymond Youssefyeh, Scott I. Klein, Henry F. Campbell, Donald E. Kuhla
  • Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
    Patent number: 4839369
    Abstract: Aryl and Heteroaryl Ethers are used for their anti-inflammatory and anti-allergic properties.
    Type: Grant
    Filed: March 13, 1986
    Date of Patent: June 13, 1989
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: Raymond Youssefyeh, Utpal Chakraborty, Ernest Magnien, Rohit Desai